Fig. 8From: Lysine lactylation (Kla) might be a novel therapeutic target for breast cancerDrug susceptibility analysis. The role of CCR7 (A), IGFBP6 (B), NDUFAF6 (C), OVOL1 (D) and SDC1 (E) on BC drug resistanceBack to article page